Objective: This comparative in vitro study examined the effects of all known gp130 cytokines on murine corticotroph AtT-20 cell function. Methods: Cytokines were tested at equimolar concentrations from 0.078 to 10 nM. Tyrosine phosphorylation of the signal transducer and activator of transcription (STAT)3 and STAT1, the STATdependent suppressor of cytokine signaling (SOCS)-3 promoter activity, SOCS-3 gene expression, STAT-dependent POMC promoter activity and adrenocorticotropic hormone (ACTH) secretion were determined. Results: Leukemia inhibitory factor (LIF), human oncostatin M (OSM) and cardiotrophin (CT)-1 (LIFR/gp130 ligands), as well as ciliary neurotrophic factor (CNTF) and novel neurotrophin-1/B-cell stimulating factor-3 (CNTFR·/LIFR/ gp130 ligands) are potent stimuli of corticotroph cells in vitro. In comparison, interleukin (IL)-6 (IL-6R/gp130 ligand) and IL-11 (IL-11R/gp130 ligand) exhibited only modest direct effects on corticotrophs, while murine OSM (OSMR/gp130 ligand) showed no effect. Conclusion: (i) CNTFR complex ligands are potent stimuli of corticotroph function, comparable to LIFR complex ligands; (ii) IL-6 and IL-11 are relatively weak direct stimuli of corticotroph function; (iii) differential effects of human and murine OSM suggest that LIFR/gp130 (OSMR type I) but not OSMR/gp130 (OSMR type II) are involved in corticotroph signaling. (iv) CT-1 has the hitherto unknown ability to stimulate corticotroph function, and (v) despite redundant immuno-neuroendocrine effects of different gp130 cytokines, corticotroph cells are preferably activated through the LIFR and CNTFR complexes.
Introduction
The gp130 cytokine family currently encompasses seven members, namely leukemia inhibitory factor LIF (LIF), oncostatin M (OSM), cardiotrophin (CT)-1, ciliary neurotrophic factor (CNTF), novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3), interleukin (IL)-6 and IL-11 [1] [2] [3] . The common receptor subunit gp130 associates with specific receptor subunits, resulting in the heterodimeric receptor complexes LIFR/gp130 and OSMR/gp130, the tripartite receptor complex CNTFR·/ LIFR/gp130 and the homodimeric receptor complexes IL-6R/gp130 and IL-11R/gp130 [1] [2] [3] . Several gp130 cytokines have been shown to be important modulators of hypothalamo-pituitary-adrenal (HPA) and stimulates corticotroph axis function in various states of stress or inflammation [2] [3] [4] [5] . Especially the action of LIF has been well characterized at pituitary corticotroph level, using the in vitro model of murine corticotroph AtT-20 cells. LIF binds to the LIFR/gp130 complex and stimulates corticotroph Janus kinase (Jak) and signal transducer and activator of transcription (STAT) signaling and subsequent STAT-dependent POMC gene expression and adrenocorticotropic hormone (ACTH) secretion [2, 5] . Also, the role of STAT-dependent suppressor of cytokine signaling (SOCS)-3 gene expression and its role as an endogenous negative regulator of cytokine-induced corticotroph function has been examined by experiments using LIF as a corticotroph stimulus [6] . Stimulatory effects on corticotroph cell function in vitro have also been described for human OSM (hOSM) [7] [8] [9] [10] [11] , CNTF and NNT-1/BSF-3 [12] , IL-6 [13] [14] [15] [16] and IL-11 [17] , respectively. However, as these effects have been investigated under various conditions, these studies cannot show the relative potency of each gp130 cytokine in corticotroph function. To the best of our knowledge, no studies have been published regarding the effects of CT-1 and murine OSM (mOSM) on corticotroph cells.
In the current study, we compared the effects of equimolar concentrations of all known gp130 cytokines on murine corticotroph AtT-20 cell function in vitro. Despite obvious redundancy of gp130 cytokines as immunoneuroendocrine modulators of HPA axis activity, this study demonstrates a specific role of gp130 cytokines in the corticotroph-stimulating function. Our data show that the ligands of the LIFR and CNTFR complexes are the major direct stimuli of corticotroph function, as indicated by STAT tyrosine phosphorylation, STAT-dependent SOCS-3 promoter activity and gene expression and POMC promoter activity and ACTH secretion.
Materials and Methods

Materials
Recombinant human (rh)NNT-1/BSF-3 was expressed in Escherichia coli [18] and stocked in a solution containing 5 mM sodium citrate, pH 4. All other cytokines tested were diluted in the same sodium citrate buffer, and the buffer solution was used as a control. Recombinant murine (rm)LIF was purchased from Chemicon International (Temecula, Calif., USA). All other cytokines, i.e. rhOSM, rmCT-1, rhCNTF, rmIL-6, rmIL-11 and rmOSM were purchased from R&D Systems (Minneapolis, Minn., USA).
Cell Culture
AtT-20/D16v-F2 cells were cultured in DMEM supplemented with 10% fetal calf serum as described recently [12] . Cells were appropriately plated and grown for 48 h. Afterwards, cells were preincubated with serum-depleted medium (containing 0.2% BSA) for 24 h and subsequently incubated with equimolar concentrations of each cytokine tested.
Northern Blot Analysis
Northern blot analysis was performed as described recently [12] . Briefly, RNA was extracted using TRIZOL ® (Invitrogen, Karlsruhe, Germany) and 20 Ìg total RNA per lane were electrophoresed and transferred to a nylon membrane. Using random-primed DNA labeling, a SOCS-3 probe template (nt 15-762, GeneBank Accession U88328) and a ß-actin DECAprobe ® (Ambion, Austin, Tex., USA) were labeled with (·-32 P)CTP. Following hybridization with QuickHyb Rapid ® (Stratagene, La Jolla, Calif., USA) autoradiographs were exposed to Kodak Biomax MS ® film (Eastman Kodak, Rochester, N.Y., USA).
Luciferase Assay
Transient transfection of AtT-20 cells with a -706/+64 rat POMC promoter-luciferase construct in PGEM7Z vector (kindly provided by Dr. Malcolm Low, Vollum Institute, Portland, Oreg., USA) or a -2757/+929 mSOCS-3 promoter-luciferase construct in pGL3Basic vector [19] was performed with Superfect ® (Quiagen, Hilden, Germany), as described recently [12] . In the current experiments, luciferase activities were measured in untreated controls and cells treated with equimolar concentrations (10 nM ) of various gp130 cytokines. The relative increase in untreated vs. stimulated luciferase activity was determined for each experiment.
Protein Extraction and Western Blotting
Protein extraction, SDS gel electrophoresis and Western blotting was performed as described recently [12] . Tyrosine phosphorylation was detected with specific primary antibodies against phosphorylated STAT3 (pSTAT3) and pSTAT1 (Upstate Biotechnology, Lake Placid, N.Y., USA) and a peroxidase conjugated secondary antibody (Pierce, Rockford, Ill., USA). Peroxidase was detected by the chemiluminescent substrate SuperSignal West Dura Extended Duration Substrate (Pierce) and membranes exposed to XOMAT-AR ® film (Eastman Kodak). For the determination of protein loading, blots were stripped and re-incubated with antibodies to STAT3 and STAT1 (Santa Cruz Biotechnology, Santa Cruz, Calif., USA), respectively. 
ACTH Assay
Statistical Analysis
Densitometric analysis of specific bands in Northern blots was performed with NIH Image 1.59 software, and JMP 5.0.1 software was used for statistical analysis. The data are expressed as means B In a dose-response study, tyrosine phosphorylation of STAT3 by various gp130 cytokines ranging from 0.078 to 10 nM was examined (2 independently performed experiments, fig. 3A , B). STAT3 phosphorylation was detected with concentrations as low as 0.078 to 0.312 nM for hOSM, LIF, CT-1, and NNT-1/BSF-3. In contrast, higher concentrations of 0.625-2.5 nM were required to induce STAT3 phosphorylation by CNTF, IL-11 and IL-6. Cytokine-induced STAT3 phosphorylation seemed to reach a plateau when using concentrations of 5.0-10.0 nM of each respective cytokine. mOSM did not induce STAT3 phosphorylation in AtT-20 cells at any concentration tested.
Results
Tyrosine Phosphorylation of STAT3 and STAT1 by Various gp130 Cytokines
SOCS-3 Promoter Activity and Gene Expression by Various gp130 Cytokines
Promoter activity of a murine -2757/+929 SOCS-3 promoter-luciferase construct ( fig. 4A ) and SOCS-3 mRNA expression ( fig. 4B ) were examined following incubation of AtT-20 cells with different gp130 cytokines in an equimolar concentration of 10 nM. SOCS-3 promoter activity was significantly stimulated 3-to 5-fold above pSTAT1) and protein loading of the respective STAT1 protein was determined by the use of specific antibodies. A Using densitometric analysis, the ratio of pSTAT1 vs. STAT1 for each treatment group was determined and the respective ratio of the control group was set at 1.0. The relative ratio of tyrosine STAT1 phosphorylation was calculated in comparison to this negative control group. Means B SE of 3 independently performed experiments (significant differences are indicated: * p ! 0.05; ** p ! 0.01; *** p ! 0.001, vs. control). B One representative Western blot out of 3 performed. 4A ). Using Northern blot analysis, SOCS-3 mRNA expression was potently induced at 45 min by NNT-1/BSF-3, CNTF, CT-1, LIF and hOSM. A weak stimulation was also induced by IL-6 and IL-11, while mOSM exhibited no effect. A representative experiment out of three is shown ( fig. 4B ).
POMC Promoter Activity and ACTH Secretion by Various gp130 Cytokines
Promoter activity of a -706/+64 rat POMC promoter-luciferase construct ( fig. 5A ) and ACTH secretion ( fig. 5B ) was examined following incubation of AtT-20 cells with different gp130 cytokines in an equimolar concentration of 10.0 nM. POMC promoter activity was significantly stimulated 2-to 4-fold above baseline by NNT-1/BSF-3, CNTF, CT-1, LIF and hOSM. In contrast, no significant increase in promoter activity was detected in this series of experiments by mOSM, IL-6 and IL-11, respectively. Results are the mean values of four independently performed experiments with n = 3 per experiment. 
CNTFR Complex Ligands Are Potent Stimuli of Corticotroph Function, Comparable to LIFR Complex Ligands
The CNTFR·/LIFR/gp130 complex binds specifically CNTF as well as the recently cloned cytokine NNT-1/ BSF-3 [18, [19] [20] [21] [22] . Recently, we have demonstrated NNT-1/BSF-3 to be a potent stimulator of corticotroph function in vitro inducing Jak-STAT-dependent gene expression, negatively regulated by SOCS-3 [12] . CNTF was also found to be a stimulator of corticotroph function [12] . The current data, using equimolar concentrations of each cytokine tested, confirm our previous finding that NNT-/BSF-3 and CNTF are potent modulators of corticotroph function. NNT-1/BSF-3 is a similarly potent modulator of corticotroph function as are LIF, hOSM and CT-1 (LIFR/gp130 ligands). In comparison to NNT-1/ BSF-3, CNTF seems to be less potent in the stimulation of corticotroph function in vitro.
IL-6 and IL-11 Are Relatively Weak Direct Stimuli of Corticotroph Function
IL-6R is expressed in fetal [10] and postmortem human pituitaries [23] and pituitary corticotroph adenomas [23] . IL-6 has been demonstrated to stimulate POMC gene expression and ACTH secretion in human corticotroph adenoma cell cultures [24] . Also, the IL-6R is expressed in murine corticotrophs [25] and corticotroph AtT-20 cells (data not shown). In AtT-20 cells, IL-6 has been reported to stimulate POMC gene expression [15] and ACTH secretion [13, 14, 16] . Also, in our current study, IL-6 modestly but significantly stimulates ACTH secretion, but demonstrates no significant effect on the POMC promoter construct. IL-6 also fails to significantly stimulate STAT-dependent SOCS-3 promoter activity and has only a slight effect on SOCS-3 gene expression. In comparison to equimolar concentrations of other gp130 cytokines, IL-6 shows only a minor effect as direct stimulator of corticotroph AtT-20 cell function in vitro. These data are similar to our previous observation of IL-6 exhibiting no significant stimulation of STAT-dependent SOCS-3 promoter activation in AtT-20 cells [26] . However, these in vitro findings do not diminish the putative major role of IL-6 as an inflammatory cytokine stimulating HPA axis activation. Firstly, IL-6 has been shown to induce the secretion of arginine vasopressin from the hypothalamus [27] and corticotrophin-releasing hormone from immortalized cell lines [28] , thus IL-6 probably indirectly stimulates corticotroph function via hypothalamic activation. However, IL-6 injection in mice deficient in corticotrophin-releasing hormone also results in a profound increase in ACTH levels, even higher than in wildtype animals [25] . This might be explained by indirect effects of IL-6 via other paracrine/endocrine mediators as well as some direct stimulatory effects of IL-6 on pituitary corticotrophs. Paracrine effects of IL-6 might also be responsible for the finding of IL-6 being almost equally potent to LIF and hOSM in inducing ACTH secretion from primary human fetal pituitary cultures [10] . Secondly, IL-6 is a potent direct stimulator of adrenocortical function in vitro [29, 30] .
Expression of the IL-11R has been demonstrated in postmortem human pituitaries [17, 23] and pituitary corticotroph adenomas [23] , as well as murine pituitaries [17] and corticotroph AtT-20 cells [17] . We have previously shown IL-11 to stimulate STAT-dependent SOCS-3 and POMC gene expression and ACTH secretion in AtT-20 cells [17] . The current data, using equimolar amounts of each cytokine tested, exhibit IL-11 to be a relatively weak inducer of corticotroph function in comparison to other gp130 cytokines. While in our previous studies a modest but significant effect of IL-11 on SOCS-3 and POMC promoter activity could be demonstrated [17, 31] , in the current study no significant induction of SOCS-3 and POMC promoter activity was observed. These discrepant findings might be explained by varying condi-tions for cell culture and luciferase assay. This observation again underlines the necessity for comparative studies in order to directly compare the potency of different cytokines.
hOSM and mOSM Have Different Effects on Murine Corticotrophs, Suggesting that LIFR/gp130 (OSMR Type I), but Not OSMR/gp130 (OSMR Type II) Is Important in Corticotroph Signaling
We show differential effects of human and murine OSM on corticotroph function. While cloning of hOSM has been reported in 1989 [32] , the cloning of mOSM was first published in 1996 [33] . Earlier studies using hOSM demonstrated stimulation of basal and corticotrophinreleasing hormone-induced POMC transcription and ACTH secretion in murine corticotroph AtT-20 cells [7] [8] [9] as well as ACTH secretion in rat primary pituitary cultures [11, and Kim person. commun.] and in human fetal primary pituitary cultures [10] . In human cells, hOSM can bind to the LIFR/gp130 (OSMR type I) as well as to the OSMR/gp130 (OSMR type II) complex [34] [35] [36] . Due to strict species specificity of OSM binding to the OSMR/ gp130 complex [36] , in murine cells hOSM binds exclusively to the LIFR/gp130 complex [34] . Thus, the earlier studies [7] [8] [9] 11] did not examine the putative role of the OSMR/gp130 complex in corticotroph function, but rather the LIFR/gp130 physiology [34] . We therefore compared in murine corticotroph AtT-20 cells the effects of hOSM, acting as a ligand to the LIFR/gp130 complex in murine cell systems [34, 36] , with the effects of mOSM, binding exclusively to the OSMR/gp130 complex but failing to bind to the LIFR/gp130 complex [34] [35] [36] . Incubation of AtT-20 cells with hOSM resulted in a potent stimulation of STAT3 and STAT1 comparable to the stimulation induced by LIF. In addition, STAT-dependent POMC promoter activity and ACTH secretion was also potently stimulated by hOSM, as had been described before [7] [8] [9] . In contrast, incubation of AtT-20 cells with mOSM failed to induce any STAT-dependent downstream events ( fig. 1-5 ), while bioactivity of the mOSM used was demonstrated in murine adrenocortical Y-1 cells [37] . RT-PCR expression studies of the different receptor subunits involved in LIFR/gp130 and OSMR/gp130 complex formation exhibited murine pituitary tissue and corticotroph AtT-20 cells to express gp130 and LIFR subunits [12] . In contrast, expression of the OSMR subunit was only detected in pituitary tissue, while AtT-20 cells did not express the OSMR subunit (data not shown). Our data demonstrate hOSM and mOSM to display differential effects on murine corticotroph function. While hOSM (associated with OSMR type I) is a potent stimulus of corticotroph function, mOSM (association with OSMR type II) has no significant effects.
CT-1 Is a New Modulator of Corticotroph Function
CT-1 has originally been named for its ability to stimulate hypertrophy of cardiac myocytes [38] . CT-1 is expressed in the heart and various other tissues [38] . CT-1 signaling involves the LIFR/gp130 complex [39] . In addition, for CT-1 signaling a third specific receptor component has been suggested [39] , which would result in a CT-1R/LIFR/gp130 complex similar to the tripartite CNTFR·/LIFR/gp130 complex. In vivo, systemic administration of CT-1 alone and combined with IL-1 resulted in an increase in corticosterone levels [40] , which might be due to HPA axis activation at various levels, e.g. pituitary or adrenal. In AtT-20 cells, CT-1 potently stimulates corticotroph STAT phosphorylation, STAT-dependent SOCS-3 promoter activity and gene expression as well as ACTH secretion. The magnitude of corticotroph activation by CT-1 is comparable to the effects observed by LIF, hOSM, NNT-1/BSF-3 or CNTF. Thus, we could demonstrate CT-1 to be a potent modulator of corticotroph cell function in vitro. No expression of CT-1 could be demonstrated by RT-PCR in postmortem human pituitaries and various pituitary tumors including corticotroph adenomas [23] , suggesting no role of CT-1 as an auto-/paracrine factor in pituitary function. However, CT-1 can be measured in the circulation, and CT-1 levels in blood were found to correlate with the degree of heart failure in man [41, 42] . So, stimulatory effects of CT-1 on pituitary corticotroph function might be of endocrine instead of auto-/paracrine mode. Patients with chronic heart failure and cachexia have been shown to exhibit increased serum levels of cortisol [43] , which -according to our data -might be partially mediated by endocrine stimulation of the HPA axis by CT-1. This hypothesis merits further evaluation.
In summary, this comparative in vitro study of the action of gp130 cytokines on murine corticotroph AtT-20 cells shows LIF, hOSM, CT-1, CNTF and NNT-1/BSF-3 to be major stimuli of the corticotroph Jak-STAT signaling cascade. In contrast, IL-6 and IL-11 show only modest effects on corticotroph function, whereas no significant effect of mOSM on corticotroph function could be detected. In conclusion, LIFR ligands (LIF, hOSM, CT-1) and CNTFR ligands (CNTF, NNT-1/BSF-3) are similarly potent direct stimuli of corticotroph function in vitro. CT-1 is a hitherto unknown modulator of corticotroph function in vitro, which might act by endocrine rather than para-/autocrine mechanisms. Differential effects of hOSM and mOSM on corticotroph function demonstrate the LIFR/gp130 complex (OSMR type I) but not OSMR/ gp130 (OSMR type II) to be of physiologic relevance in neuroimmunoendocrine modulation of corticotroph function. Thus, despite redundant effects of several gp130 cytokines on corticotroph function, this study could demonstrate specific differences in the potency of different gp130 cytokines to activate corticotroph Jak-STAT signaling and function. This specific pattern of gp130 cytokine action on corticotrophs further contributes to our understanding of the neuroimmunomodulation of corticotroph function. Further comparative studies should also examine differences in gp130 cytokines with respect to their ability to directly induce corticotroph versus adrenocortical function. The -at first glance -redundant neuroimmunoendocrine cytokine network might turn out to have distinct specific 'major players' at corticotroph as well as at adrenocortical level.
